86 related articles for article (PubMed ID: 18854836)
1. Cell cycle times of short-term cultures of brain cancers as predictors of survival.
Furneaux CE; Marshall ES; Yeoh K; Monteith SJ; Mews PJ; Sansur CA; Oskouian RJ; Sharples KJ; Baguley BC
Br J Cancer; 2008 Nov; 99(10):1678-83. PubMed ID: 18854836
[TBL] [Abstract][Full Text] [Related]
2. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.
Asgari S; Röhrborn HJ; Engelhorn T; Stolke D
Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069
[TBL] [Abstract][Full Text] [Related]
3. Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis.
Yousaf J; Hills C; Dixit S; Achawal S; O'Brien D; Greenman J; Scott IS
Br J Neurosurg; 2013 Dec; 27(6):752-8. PubMed ID: 23477614
[TBL] [Abstract][Full Text] [Related]
4. Stem cell studies of human malignant brain tumors. Part 2: Proliferation kinetics of brain-tumor cells in vitro in early-passage cultures.
Pertuiset B; Dougherty D; Cromeyer C; Hoshino T; Berger M; Rosenblum ML
J Neurosurg; 1985 Sep; 63(3):426-32. PubMed ID: 4020471
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
[TBL] [Abstract][Full Text] [Related]
6. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis in primary tumors of the central nervous system. A patient material from the Norwegian Radium Hospital 1960-94].
Lote K; Gundersen S; Hannisdal E; Hager B; Stenwig AE; Tverå K; Berg-Johnsen J; Skullerud K; Bakke SJ; Hirschberg H
Tidsskr Nor Laegeforen; 1996 Apr; 116(11):1320-4. PubMed ID: 8658412
[TBL] [Abstract][Full Text] [Related]
8. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
9. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
10. Astrocytoma derived short-term cell cultures retain molecular signatures characteristic of the tumour in situ.
Potter NE; Phipps K; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Thomas DG; Rees J; Darling JL; Warr TJ
Exp Cell Res; 2009 Oct; 315(16):2835-46. PubMed ID: 19523942
[TBL] [Abstract][Full Text] [Related]
11. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
[TBL] [Abstract][Full Text] [Related]
12. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
13. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
15. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
16. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
Noël G; Quetin P; Heymann S; Karamanoukian D; Schott R
Cancer Radiother; 2009 Jan; 13(1):17-23. PubMed ID: 19091619
[TBL] [Abstract][Full Text] [Related]
19. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas.
Yamashita Y; Kumabe T; Higano S; Watanabe M; Tominaga T
Neurol Res; 2009 Nov; 31(9):940-6. PubMed ID: 19138469
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
